|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.510 CAD | +2.03% |
|
0.00% | -34.63% |
| 13/05 | Organigram Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026 | CI |
| 12/05 | Organigram Global Inc. Updates Revenue Guidance for the Fiscal Year 2026 | CI |
Company Valuation: Organigram Global Inc.
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 875.5 | 382.7 | 144.9 | 266 | 378.8 | 208.3 | - | - |
| Change | - | -56.28% | -62.13% | 83.53% | 42.4% | -45% | - | - |
| Enterprise Value (EV) | 692.2 | 284.4 | 144.9 | 266 | 378.8 | 208.3 | 208.3 | 208.3 |
| Change | - | -58.92% | -49.03% | 83.53% | 42.4% | -45% | 0% | 0% |
| P/E Ratio | -5.73x | -26.5x | -0.59x | -5.14x | -14.5x | 11.4x | 37x | 13.5x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.3x | -0x | 0.1x | 0.2x | -0x | -0.5x | 0x |
| Capitalization / Revenue | 11.1x | 2.62x | 0.9x | 1.66x | 1.46x | 0.61x | 0.47x | 0.47x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.61x | 0.47x | 0.47x |
| EV / EBITDA | -0x | 0x | 0x | 0x | 0x | 8.94x | 4.62x | 3.69x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -12.7x | 18x | - |
| EV / FCF | -0x | -0x | -0x | -0x | -0x | -11.6x | 7.16x | - |
| FCF Yield | -4.61% | -22.2% | -46.9% | -0.32% | -6.5% | -8.59% | 14% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.04 | -0.184 | -3.058 | -0.477 | -0.194 | 0.13 | 0.04 | 0.11 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 79.16 | 145.8 | 161.6 | 159.8 | 259.2 | 339.6 | 440.8 | 441.4 |
| EBITDA 1 | -30.03 | 3.484 | 5.951 | 8.416 | 21.86 | 23.3 | 45.12 | 56.5 |
| EBIT 1 | -76.99 | -34.11 | -275.8 | -35.67 | -15.3 | -16.43 | 11.55 | - |
| Net income 1 | -130.7 | -14.28 | -248.6 | -45.44 | -24.76 | 18.88 | 6.53 | - |
| Net Debt | -183.2 | -98.37 | - | - | - | - | - | - |
| Reference price 2 | 11.680 | 4.880 | 1.800 | 2.450 | 2.820 | 1.480 | 1.480 | 1.480 |
| Nbr of stocks (in thousands) | 74,954 | 78,427 | 80,520 | 1,08,573 | 1,34,326 | 1,40,775 | - | - |
| Announcement Date | 23/11/21 | 29/11/22 | 19/12/23 | 18/12/24 | 16/12/25 | - | - | - |
1CAD in Million2CAD
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 11.38x | - | - | - | 15Cr | |
| 13.46x | - | - | - | 12Cr | |
| -1.4x | 0.69x | 3.05x | - | 11Cr | |
| -2.01x | 1.12x | 6.1x | - | 9.89Cr | |
| Average | 5.36x | 0.91x | 4.57x | 11.95Cr | ||
| Weighted average by Cap. | 6.14x | 0.89x | 4.48x |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- OGI Stock
- Valuation Organigram Global Inc.
Select your edition
All financial news and data tailored to specific country editions
